Literature DB >> 19471915

Partial splenic embolization in a child with Gaucher disease, massive splenomegaly and severe thrombocytopenia.

Andres H Pena1, Paige Kaplan, Jaya Ganesh, Egor Clevac, Anne Marie Cahill.   

Abstract

A 13-month-old boy with Gaucher disease presented with severe thrombocytopenia, anemia and massive splenomegaly. In addition he had significant respiratory compromise caused by abdominal compartment syndrome, requiring mechanical ventilation. Because of the degree of respiratory compromise and his existing bone marrow suppression, splenic artery embolization was chosen as an alternative to splenectomy. Splenic artery embolization was performed using 355-500-microm polyvinyl alcohol particles, with 70% ablation achieved. Within 24 h of the procedure the platelet count had risen to greater than 70,000/mm(3) and to more than 170,000/mm(3) on postoperative day 4. At the 8-month follow-up the splenic size had decreased from 18 cm to 8 cm, with a platelet count of 578,000/mm(3). Partial splenic embolization provides a minimally invasive alternative to splenectomy in patients with Gaucher disease with massive splenomegaly and bone marrow suppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471915     DOI: 10.1007/s00247-009-1303-9

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Evaluation of splenic embolization in patients with portal hypertension and hypersplenism.

Authors:  A Alwmark; S Bengmark; P Gullstrand; B Joelsson; A Lunderquist; T Owman
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

2.  Partial splenic embolization in the management of hypersplenism secondary to Gaucher disease.

Authors:  B D Thanopoulos; C A Frimas
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

3.  Partial embolization of the spleen in patients with thalassemia.

Authors:  P Stanley; T C Shen
Journal:  J Vasc Interv Radiol       Date:  1995 Jan-Feb       Impact factor: 3.464

4.  Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.

Authors:  Hans Andersson; Paige Kaplan; Katherine Kacena; John Yee
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

5.  Partial splenic embolization in five children with hypersplenism: effects of reduced-volume embolization on efficacy and morbidity.

Authors:  R K Harned; H R Thompson; D A Kumpe; M R Narkewicz; R J Sokol
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

6.  Gaucher disease: treatment of hypersplenism with splenic embolization.

Authors:  B D Thanopoulos; C A Frimas; S P Mantagos; N G Beratis
Journal:  Acta Paediatr Scand       Date:  1987-11

7.  Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.

Authors:  Pramod K Mistry; Sandra Sirrs; Alicia Chan; Mark R Pritzker; Thomas P Duffy; Marie E Grace; David P Meeker; Martin E Goldman
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

8.  Partial splenic embolization in children with hypersplenism.

Authors:  D A Kumpe; C M Rumack; D H Pretorius; T J Stoecker; G P Stellin
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

  8 in total
  4 in total

Review 1.  Revised recommendations for the management of Gaucher disease in children.

Authors:  Paige Kaplan; Hagit Baris; Linda De Meirleir; Maja Di Rocco; Amal El-Beshlawy; Martina Huemer; Ana Maria Martins; Ioana Nascu; Marianne Rohrbach; Lynne Steinbach; Ian J Cohen
Journal:  Eur J Pediatr       Date:  2012-07-08       Impact factor: 3.183

2.  Successful interventional management of abdominal compartment syndrome caused by blunt liver injury with hemorrhagic diathesis.

Authors:  Hiroyuki Tokue; Azusa Tokue; Yoshito Tsushima
Journal:  World J Emerg Surg       Date:  2014-03-22       Impact factor: 5.469

Review 3.  Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).

Authors:  Melissa Wasserstein; Carlo Dionisi-Vici; Roberto Giugliani; Wuh-Liang Hwu; Olivier Lidove; Zoltan Lukacs; Eugen Mengel; Pramod K Mistry; Edward H Schuchman; Margaret McGovern
Journal:  Mol Genet Metab       Date:  2018-11-29       Impact factor: 4.797

4.  Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis.

Authors:  Lei Zhang; Zhan-Guo Zhang; Xin Long; Fei-Long Liu; Wan-Guang Zhang
Journal:  Risk Manag Healthc Policy       Date:  2020-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.